Synergistic integration of Netrin and ephrin axon guidance signals by spinal motor neurons

  1. Sebastian Poliak
  2. Daniel Morales
  3. Louis-Philippe Croteau
  4. Dayana Krawchuk
  5. Elena Palmesino
  6. Susan Morton
  7. Cloutier Jean-François
  8. Frederic Charron
  9. Matthew B Dalva
  10. Susan L Ackerman
  11. Tzu-Jen Kao
  12. Artur Kania  Is a corresponding author
  1. Columbia University, United States
  2. Institut de recherches cliniques de Montreal, Canada
  3. Montreal Neurological Institute, Canada
  4. Department of Neuroscience, The Farber Institute for Neurosciences, Jefferson Hospital for Neuroscience, United States
  5. Howard Hughes Medical Institute, The Jackson Laboratory, United States
  6. Taipei Medical University, Taiwan

Abstract

During neural circuit assembly, axonal growth cones are exposed to multiple guidance signals at trajectory choice points. While axonal responses to individual guidance cues have been extensively studied, less is known about responses to combination of signals and underlying molecular mechanisms. Here, we studied the convergence of signals directing trajectory selection of spinal motor axons entering the limb. We first demonstrate that Netrin-1 attracts and repels distinct motor axon populations, according to their expression of Netrin receptors. Quantitative in vitro assays demonstrate that motor axons synergistically integrate both, attractive or repulsive Netrin-1 signals together with repulsive ephrin signals. Our investigations of the mechanism of ephrin-B2 and Netrin-1 integration demonstrate that the Netrin receptor Unc5c and the ephrin receptor EphB2 can form a complex in a ligand-dependent manner and that Netrin-ephrin synergistic growth cones responses involve the potentiation of Src family kinase signaling, a common effector of both pathways.

Article and author information

Author details

  1. Sebastian Poliak

    Department of Neuroscience, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Daniel Morales

    Neural Circuit Development Laboratory, Institut de recherches cliniques de Montreal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  3. Louis-Philippe Croteau

    Neural Circuit Development Laboratory, Institut de recherches cliniques de Montreal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  4. Dayana Krawchuk

    Neural Circuit Development Laboratory, Institut de recherches cliniques de Montreal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  5. Elena Palmesino

    Neural Circuit Development Laboratory, Institut de recherches cliniques de Montreal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Susan Morton

    Department of Neuroscience, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Cloutier Jean-François

    Montreal Neurological Institute, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  8. Frederic Charron

    Institut de recherches cliniques de Montreal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  9. Matthew B Dalva

    Thomas Jefferson University, Department of Neuroscience, The Farber Institute for Neurosciences, Jefferson Hospital for Neuroscience, Philadelphia, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Susan L Ackerman

    Howard Hughes Medical Institute, The Jackson Laboratory, Bar Harbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Tzu-Jen Kao

    Graduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
    Competing interests
    The authors declare that no competing interests exist.
  12. Artur Kania

    Neural Circuit Development Lab, Institut de recherches cliniques de Montreal, Montreal, Canada
    For correspondence
    artur.kania@ircm.qc.ca
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Graeme W Davis, University of California, San Francisco, United States

Ethics

Animal experimentation: All experimental procedures were approved by the Animal Care Committee at the Institut de Recherches Cliniques de Montréal, in accordance with the regulations of the Canadian Council on Animal Care. The following protocol reference numbers were used: 2005-03, 2008-18, 2009-10, 2011-30 and 2012-22.

Version history

  1. Received: August 13, 2015
  2. Accepted: December 2, 2015
  3. Accepted Manuscript published: December 3, 2015 (version 1)
  4. Version of Record published: February 12, 2016 (version 2)

Copyright

© 2015, Poliak et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,235
    views
  • 782
    downloads
  • 69
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sebastian Poliak
  2. Daniel Morales
  3. Louis-Philippe Croteau
  4. Dayana Krawchuk
  5. Elena Palmesino
  6. Susan Morton
  7. Cloutier Jean-François
  8. Frederic Charron
  9. Matthew B Dalva
  10. Susan L Ackerman
  11. Tzu-Jen Kao
  12. Artur Kania
(2015)
Synergistic integration of Netrin and ephrin axon guidance signals by spinal motor neurons
eLife 4:e10841.
https://doi.org/10.7554/eLife.10841

Share this article

https://doi.org/10.7554/eLife.10841

Further reading

    1. Developmental Biology
    2. Medicine
    Stephen E Flaherty III, Olivier Bezy ... Zhidan Wu
    Research Article

    From a forward mutagenetic screen to discover mutations associated with obesity, we identified mutations in the Spag7 gene linked to metabolic dysfunction in mice. Here, we show that SPAG7 KO mice are born smaller and develop obesity and glucose intolerance in adulthood. This obesity does not stem from hyperphagia, but a decrease in energy expenditure. The KO animals also display reduced exercise tolerance and muscle function due to impaired mitochondrial function. Furthermore, SPAG7-deficiency in developing embryos leads to intrauterine growth restriction, brought on by placental insufficiency, likely due to abnormal development of the placental junctional zone. This insufficiency leads to loss of SPAG7-deficient fetuses in utero and reduced birth weights of those that survive. We hypothesize that a ‘thrifty phenotype’ is ingrained in SPAG7 KO animals during development that leads to adult obesity. Collectively, these results indicate that SPAG7 is essential for embryonic development and energy homeostasis later in life.

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine
    Nikola Sekulovski, Jenna C Wettstein ... Kenichiro Taniguchi
    Research Article

    Amniogenesis, a process critical for continuation of healthy pregnancy, is triggered in a collection of pluripotent epiblast cells as the human embryo implants. Previous studies have established that bone morphogenetic protein (BMP) signaling is a major driver of this lineage specifying process, but the downstream BMP-dependent transcriptional networks that lead to successful amniogenesis remain to be identified. This is, in part, due to the current lack of a robust and reproducible model system that enables mechanistic investigations exclusively into amniogenesis. Here, we developed an improved model of early amnion specification, using a human pluripotent stem cell-based platform in which the activation of BMP signaling is controlled and synchronous. Uniform amniogenesis is seen within 48 hr after BMP activation, and the resulting cells share transcriptomic characteristics with amnion cells of a gastrulating human embryo. Using detailed time-course transcriptomic analyses, we established a previously uncharacterized BMP-dependent amniotic transcriptional cascade, and identified markers that represent five distinct stages of amnion fate specification; the expression of selected markers was validated in early post-implantation macaque embryos. Moreover, a cohort of factors that could potentially control specific stages of amniogenesis was identified, including the transcription factor TFAP2A. Functionally, we determined that, once amniogenesis is triggered by the BMP pathway, TFAP2A controls the progression of amniogenesis. This work presents a temporally resolved transcriptomic resource for several previously uncharacterized amniogenesis states and demonstrates a critical intermediate role for TFAP2A during amnion fate specification.